课题基金 / 基金详情

GENE REGULATION GOVERNING T LYMPHOCYTE FATE DECISIONS

GENE REGULATION GOVERNING T LYMPHOCYTE FATE DECISIONS
控制 T 淋巴细胞命运决定的基因调控
批准号:
8438552
负责人:
Takeshi Egawa
金额:
$38.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-24 至 2017-08-31

项目摘要

项目成果

Takeshi Egawa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Abstract: Cell lineage decisions during development require strict gene regulation by complex networks of multiple transcription factors and collaborating factors. During fate decisions, key transcription factors (TFs) drive precursors into one lineage while inactivating "alternative fate genes". Silenced states of a subset of "alternativ fate genes" are heritably maintained through epigenetic silencing. Epigenetic silencing is globally important for normal cell development and commonly altered in many types of cancers. Establishment of epigenetic silencing involves recruitment of enzyme activities mediating repressive histone methylation and DNA methylation. These enzyme activities are thought to be delivered by specific sets of TFs in a locus- specific manner. However, the mechanisms by which these TFs drive cel fate decisions and then establish epigenetic silencing are not completely understood. In this proposal, we will study crosstalk between key TFs driving T cell lineage choices and epigenetic modifiers that ultimately establish cell lineage identities. T lymphocyte development is an excellent system to tackle these questions because of our strong background knowledge on developmental processes and requirements for TFs. Specifically, we will study functions of Runx transcription factors in gene repression in the context of fate decisions and epigenetic silencing of "alternative fate genes". Our efforts will be focused on study of functional collaborations between Runx proteins and their interacting factors that drive and stabilize the fate choice processes. Because Runx proteins are involved in normal development of many cell types, and their functions are frequently altered in leukemia, knowledge obtained through our study of Runx-mediated genetic and epigenetic regulation during T cell development would provide substantial insights into stable gene regulation mechanisms widely used in many cell types as well as altered genetic programs causing cancers. PUBLIC HEALTH RELEVANCE: Diverse cell types are continuously generated from stem/progenitor cells to maintain functional cell compartments. During cell differentiation, a specific set of genes is turned-on or -off by transcription factors, and these distinct states of gene expression are stably maintained. In this study, I propose to investigate the gene regulatory mechanisms that are critical for maintaining cell type diversity in animals and humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CD8 T cell fate decision instructed by IL-2
  • 批准号:
    10740087
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2022
  • 负责人:
    Takeshi Egawa
  • 依托单位:
Development of a novel mouse model with progesterone-independent susceptibility to genital HSV infection
  • 批准号:
    10615599
  • 项目类别:
  • 资助金额:
    $7.8万
  • 财政年份:
    2022
  • 负责人:
    Takeshi Egawa
  • 依托单位:
Development of a novel mouse model with progesterone-independent susceptibility to genital HSV infection
  • 批准号:
    10352920
  • 项目类别:
  • 资助金额:
    $7.88万
  • 财政年份:
    2022
  • 负责人:
    Takeshi Egawa
  • 依托单位:
Identification of progenitor CD4 T cells that support response to chronic antigen
  • 批准号:
    10449403
  • 项目类别:
  • 资助金额:
    $19.69万
  • 财政年份:
    2021
  • 负责人:
    Takeshi Egawa
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: